MC1811A1 - Extrait de plantes de l'espece nerium procede pour sa preparation et ses applications - Google Patents

Extrait de plantes de l'espece nerium procede pour sa preparation et ses applications

Info

Publication number
MC1811A1
MC1811A1 MC871885A MC1885A MC1811A1 MC 1811 A1 MC1811 A1 MC 1811A1 MC 871885 A MC871885 A MC 871885A MC 1885 A MC1885 A MC 1885A MC 1811 A1 MC1811 A1 MC 1811A1
Authority
MC
Monaco
Prior art keywords
plants
extract
applications
preparation
species nerium
Prior art date
Application number
MC871885A
Other languages
English (en)
Inventor
Ozel Huseyin-Ziya
Original Assignee
Huseyin Ziya Ozel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huseyin Ziya Ozel filed Critical Huseyin Ziya Ozel
Publication of MC1811A1 publication Critical patent/MC1811A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MC871885A 1986-05-13 1987-05-12 Extrait de plantes de l'espece nerium procede pour sa preparation et ses applications MC1811A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86272086A 1986-05-13 1986-05-13
US4843587A 1987-05-11 1987-05-11

Publications (1)

Publication Number Publication Date
MC1811A1 true MC1811A1 (fr) 1988-03-18

Family

ID=26726121

Family Applications (1)

Application Number Title Priority Date Filing Date
MC871885A MC1811A1 (fr) 1986-05-13 1987-05-12 Extrait de plantes de l'espece nerium procede pour sa preparation et ses applications

Country Status (14)

Country Link
US (1) US5135745A (fr)
JP (1) JPS6322025A (fr)
KR (1) KR880013565A (fr)
CN (1) CN87104312A (fr)
AU (1) AU626516B2 (fr)
CA (1) CA1299100C (fr)
DK (1) DK239687A (fr)
FI (1) FI872106A (fr)
IL (1) IL82516A0 (fr)
IN (1) IN165073B (fr)
MC (1) MC1811A1 (fr)
NO (1) NO871978L (fr)
NZ (1) NZ220295A (fr)
PT (1) PT84857B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003227319B2 (en) * 1998-09-24 2007-07-26 Ozelle Pharmaceuticals, Inc. Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
CA2354037A1 (fr) * 1998-09-24 2000-03-30 Ozelle Pharmaceuticals, Inc. Extrait d'une espece de laurier-rose, composition pharmaceutique et procedes de preparation associes
KR100478146B1 (ko) * 2002-08-30 2005-03-22 재단법인 포항산업과학연구원 협죽도과 식물의 잎 추출물을 함유하는 고려잔디갈색퍼짐병 방제용 조성물 및 이를 이용하여 갈색퍼짐병을방제하는 방법
US20050112059A1 (en) * 2003-10-06 2005-05-26 Phoenix Biotechnology, Inc. Enhancement of radiotherapy by an exogenous cardiac glycoside
US20050250709A1 (en) * 2003-12-19 2005-11-10 Bionaut Pharmaceuticals Anti-neoplastic agents, combination therapies and related methods
JP2005289963A (ja) * 2004-03-12 2005-10-20 Hokubu Norin Koto Gakko Koenkai 抗腫瘍剤
US20060135468A1 (en) * 2004-09-02 2006-06-22 Bionaut Pharmaceuticals, Inc. Treatment of refractory cancers using NA+/K+ ATPase inhibitors
US20070105790A1 (en) * 2004-09-02 2007-05-10 Bionaut Pharmaceuticals, Inc. Pancreatic cancer treatment using Na+/K+ ATPase inhibitors
EP1789090A2 (fr) * 2004-09-02 2007-05-30 Bionaut Pharmaceuticals, Inc. Traitement chimiotherapeutique combinatoire utilisant des inhibiteurs de na+/k+-atpase
US20080027010A1 (en) * 2004-09-02 2008-01-31 Bionaut Pharmaceuticals, Inc. Treatment of refractory cancers using Na+/K+-ATPase inhibitors
ATE509630T1 (de) * 2004-09-02 2011-06-15 Bionaut Pharmaceuticals Inc Pankreaskrebsbehandlung mit na+/k+-atpase-hemmern
WO2006044916A2 (fr) * 2004-10-18 2006-04-27 Bionaut Pharmaceuticals, Inc. Utilisation d'inhibiteurs de la na+/k+-atpase et leurs antagonistes
US20060188536A1 (en) * 2005-02-15 2006-08-24 Phoenix Biotechnology Inc. Particles from processing of oleander leaves
JP2007008879A (ja) * 2005-06-30 2007-01-18 Yanbaru Green Health:Kk 抗腫瘍剤及びこれを含有する食品
US7402325B2 (en) * 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
EP1803461A1 (fr) * 2005-12-27 2007-07-04 Heinz-Herbert Fiebig Utilisation therapeutique d'un extrait de feuilles de Nerium oleander
WO2008078362A1 (fr) * 2006-12-22 2008-07-03 The Institute Of Biological Resources Agent antitumoral et aliment qui le contient
US8486465B1 (en) * 2007-07-09 2013-07-16 Douglas CRAWFORD Therapeutic nerium oleander extract compositions and methods of using
CN101613414B (zh) * 2008-06-26 2011-09-07 中国科学院上海药物研究所 两种夹竹桃寡糖及其制备方法和用途
AU2009303460B9 (en) * 2008-10-14 2014-12-18 Nerium Biotechnology, Inc. Process for extracting cardiac glycodides and compositions
CN101416988B (zh) * 2008-12-07 2011-12-21 中国热带农业科学院热带生物技术研究所 采食长春花叶的夹竹桃天蛾幼虫粪便提取物在制备抗肿瘤药物中的用途
TR200900312A2 (tr) * 2009-01-15 2010-08-23 Levent Baş Ahmet Nerium oleander'in tip II diyabet, obezite, yüksek kolesterol ve trigliserid düzeyi ile seyreden hastalıklar ve kardiovasküler hastalıklarda kullanımı@
CN104093405A (zh) 2011-10-20 2014-10-08 奈瑞姆生物技术公司 用于治疗癌症的治疗组合
US10702567B2 (en) 2016-09-14 2020-07-07 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
ES2874187T3 (es) 2016-09-14 2021-11-04 Phoenix Biotechnology Inc Método y composiciones para el tratamiento de una infección viral
US10729735B1 (en) 2016-09-14 2020-08-04 Phoenix Biotechnology, Inc. Method and compostitions for treating coronavirus infection
US10596186B2 (en) 2016-09-14 2020-03-24 Phoenix Biotechnology, Inc. Method and compositions for treating viral infections
JP6820450B2 (ja) 2017-09-14 2021-01-27 フェニックス・バイオテクノロジー・インコーポレイテッド ウイルス感染を治療するための方法および組成物
SG11202105728YA (en) 2020-03-31 2021-11-29 Phoenix Biotechnology Inc Method and compositions for treating coronavirus infection
CA3091376C (fr) * 2020-03-31 2023-09-19 Phoenix Biotechnology, Inc. Procede et compositions pour traiter l'infection au coronavirus
US11806359B2 (en) 2020-03-31 2023-11-07 Phoenix Biotechnology, Inc. Method and compositions for treating Coronavirus infection
EP4009981B1 (fr) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Méthode et compositions pour le traitement d'une infection à coronavirus
CN112689510B (zh) * 2020-03-31 2022-02-01 菲尼克斯生物技术公司 用于治疗冠状病毒感染的方法和组合物

Also Published As

Publication number Publication date
AU626516B2 (en) 1992-08-06
CN87104312A (zh) 1988-01-13
DK239687D0 (da) 1987-05-12
AU7278587A (en) 1987-11-19
FI872106A (fi) 1987-11-14
FI872106A0 (fi) 1987-05-12
PT84857A (en) 1987-06-01
DK239687A (da) 1987-11-14
JPS6322025A (ja) 1988-01-29
CA1299100C (fr) 1992-04-21
NO871978L (no) 1987-11-16
JPH0529332B2 (fr) 1993-04-30
IN165073B (fr) 1989-08-12
PT84857B (pt) 1990-02-08
IL82516A0 (en) 1987-11-30
NZ220295A (en) 1990-04-26
US5135745A (en) 1992-08-04
NO871978D0 (no) 1987-05-13
KR880013565A (ko) 1988-12-21

Similar Documents

Publication Publication Date Title
MC1811A1 (fr) Extrait de plantes de l'espece nerium procede pour sa preparation et ses applications
FR2605185B1 (fr) Procede de culture des plantes
FR2507867B1 (fr) Procede de preparation de l'a-glycosylglycyrrhizine et applications de celle-ci
MA18729A1 (fr) Procede de preparation de l'essence de rose
FR2618451B1 (fr) Procede et installation de vinification et utilisations s'y rapportant
BE875998A (fr) Membranes d'ultrafiltration et leur procede de preparation
FR2643375B1 (fr) Procede de preparation d'extrait de serenoa repens inodore
FR2520379B1 (fr) Procede de preparation d'un disaccharide-tripeptide et d'un disaccharide-tetrapeptide possedant des proprietes immunostimulantes
PT75209A (fr) Procede de preparation d'amidobenzamides
BE873361A (fr) Procede pour ameliorer l'eclat de minerais calcitiques naturels
BE893393A (fr) Procede d'extraction et de purification de substances antineoplastiques
BE893652A (fr) Procede de preparation d'alcanols et alcanols ainsi obtenus
BE875378A (fr) Procede de preparation d'alcoylsilanes
PT80111A (fr) Procede de preparation de nouveaux arylthio-pyridinyl-alcanole et de compositions fongicides les contenant
FR2630735B1 (fr) Procede de preparations d'halogenophenols
BE893656A (fr) Procede de preparation d'alcanols et alcanols ainsi obtenus
FR2633273B1 (fr) Procede de preparation de tetraflurorure d'uranium
BE893653A (fr) Procede de preparation d'alcanols et alcanols ainsi obtenus
BE880656A (fr) Derive de 7 alpha-methoxycephalosporine et son procede de preparation
FR2666965B1 (fr) Procede de preparation d'extrait concentre d'algues.
FR2498056B2 (fr) Procede pour la preparation d'un extrait de champignons et extrait de champignons ainsi prepare
PT68322A (fr) Procede de preparation d'ethers hydrosolubles de hydroxi-flavones
FR2560199B1 (fr) Procede de preparation de l'i-brassicasterol
FR2610924B1 (fr) Procede de preparation d'hydroxybiphenyles
FR2601955B1 (fr) Procede de preparation d'alkyl et d'arylchlorosilane

Legal Events

Date Code Title Description
YP Annual fee paid